KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554,360 | -13.1% | 57,566 | -18.8% | 0.00% | – |
| Q2 2023 | $637,785 | -42.8% | 70,865 | -50.0% | 0.00% | – |
| Q1 2023 | $1,114,468 | -87.4% | 141,790 | -89.2% | 0.00% | -100.0% |
| Q4 2022 | $8,862,374 | -47.3% | 1,311,002 | +13.2% | 0.00% | -50.0% |
| Q3 2022 | $16,808,000 | +50.8% | 1,158,385 | +2.3% | 0.00% | +100.0% |
| Q2 2022 | $11,143,000 | -8.4% | 1,132,442 | +37.2% | 0.00% | 0.0% |
| Q1 2022 | $12,166,000 | +16.8% | 825,350 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $10,415,000 | -37.9% | 787,220 | -18.1% | 0.00% | 0.0% |
| Q3 2021 | $16,769,000 | -35.7% | 960,961 | -11.7% | 0.00% | -50.0% |
| Q2 2021 | $26,087,000 | -24.7% | 1,088,790 | -19.2% | 0.00% | -33.3% |
| Q1 2021 | $34,630,000 | +11.2% | 1,347,970 | -17.8% | 0.00% | 0.0% |
| Q4 2020 | $31,149,000 | +42.1% | 1,640,278 | -5.8% | 0.00% | +50.0% |
| Q3 2020 | $21,926,000 | +2.7% | 1,741,613 | -1.3% | 0.00% | 0.0% |
| Q2 2020 | $21,342,000 | +55.8% | 1,763,856 | -1.5% | 0.00% | 0.0% |
| Q1 2020 | $13,700,000 | -53.9% | 1,790,791 | +7.4% | 0.00% | -33.3% |
| Q4 2019 | $29,689,000 | +176.7% | 1,666,978 | +80.2% | 0.00% | +200.0% |
| Q3 2019 | $10,729,000 | -50.4% | 924,945 | -5.3% | 0.00% | -66.7% |
| Q2 2019 | $21,629,000 | +2.8% | 976,480 | +32.9% | 0.00% | 0.0% |
| Q1 2019 | $21,036,000 | – | 735,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |